S
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Price:
1 416 JPY
-3.34%
Market Closed
Updated:
May 15, 2024
Shin Nippon Biomedical Laboratories Ltd
Cost of Revenue
|
Shin Nippon Biomedical Laboratories Ltd
Cost of Revenue Peer Comparison
Comparables:
2309
2370
4880
2183
7079
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Cost of Revenue
-¥12.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cost of Revenue
-¥72.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
Medinet Co Ltd
TSE:2370
|
Cost of Revenue
-¥596.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
CellSource Co Ltd
TSE:4880
|
Cost of Revenue
-¥1.3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Linical Co Ltd
TSE:2183
|
Cost of Revenue
-¥8.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-14%
|
|
|
WDB coco Co Ltd
TSE:7079
|
Cost of Revenue
-¥2.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Cost of Revenue?
Cost of Revenue
-12.8B
JPY
-12.8B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Cost of Revenue amounts to -12.8B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
0%
0%
Over the last year, the Cost of Revenue growth was -29%. The average annual Cost of Revenue growth rates for Shin Nippon Biomedical Laboratories Ltd have been -19% over the past three years , -3% over the past five years .
You don't have any saved screeners yet
